SNY · Sanofi
$45.83
+0.86 (+1.91%)
At close · Aug 19
Market Cap
$107.84B
Shares
2.40B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-06 | — | |
| 6-K | 2026-07-30 | 2026-06-30 | |
| 6-K | 2026-07-30 | 2026-06-30 | |
| 6-K | 2026-07-27 | — | |
| 6-K | 2026-07-17 | — | |
| 6-K | 2026-07-07 | — | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-06-12 | — | |
| 6-K | 2026-06-08 | — | |
| 6-K | 2026-05-27 | — | |
| 6-K | 2026-05-05 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-04-27 | — | |
| 6-K | 2026-04-23 | 2026-03-31 | |
| 6-K | 2026-04-15 | — | |
| 6-K | 2026-03-31 | — | |
| 6-K | 2026-03-24 | — | |
| 6-K | 2026-03-10 | — | |
| 6-K | 2026-03-04 | — | |
| 6-K | 2026-03-03 | — | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2026-02-17 | — | |
| 20-F | 2026-02-17 | 2025-12-31 | |
| 6-K | 2026-02-12 | — | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-02-06 | — | |
| 6-K | 2026-01-29 | 2025-12-31 | |
| 6-K | 2026-01-23 | — | |
| 6-K | 2026-01-16 | — | |
| 6-K | 2026-01-09 | — | |
| 6-K | 2025-12-29 | — | |
| 6-K | 2025-12-29 | — | |
| 6-K | 2025-12-29 | — | |
| 6-K | 2025-12-23 | — | |
| 6-K | 2025-12-22 | — | |
| 6-K | 2025-12-15 | — | |
| 6-K | 2025-12-12 | — | |
| 6-K | 2025-12-03 | — | |
| 6-K | 2025-11-18 | — | |
| 6-K | 2025-11-03 | — | |
| 6-K | 2025-10-31 | — | |
| 6-K | 2025-10-28 | — | |
| 6-K | 2025-10-27 | 2025-06-30 | |
| 6-K | 2025-10-24 | 2025-09-30 | |
| 6-K | 2025-10-24 | — | |
| 6-K | 2025-10-15 | — | |
| 6-K | 2025-09-26 | — | |
| 6-K | 2025-09-22 | — | |
| 6-K | 2025-09-17 | — |
Showing 1–50 of 287 filings
Key facts
CIK
1121404
CUSIP
80105N105
13F (30d)
651 filings
608 filers
Visit website
Investor relations